Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Urolithin A is a natural metabolite produced by gut microbiota from ellagitannins found in foods like pomegranates and some berries and nuts. Its potential role in supporting or treating Metabolic Syndrome is based on preclinical and early clinical studies, rather than traditional or historical use. Animal studies have shown that Urolithin A can improve mitochondrial function, reduce inflammation, and enhance muscle health—all processes implicated in metabolic health. Specifically, Urolithin A induces mitophagy, a process of clearing dysfunctional mitochondria, which is often impaired in individuals with Metabolic Syndrome.

Some small-scale human trials have suggested that Urolithin A supplementation is safe and can improve mitochondrial biomarkers and cellular energy in older adults. However, direct evidence supporting its use specifically for Metabolic Syndrome (a cluster of conditions including insulin resistance, hypertension, obesity, and dyslipidemia) remains limited. Most available human data focus on mitochondrial health and muscle function, with only indirect implications for metabolic health.

In summary, while there is promising preclinical and early clinical evidence for Urolithin A’s role in improving cellular and mitochondrial health, studies directly demonstrating its efficacy for Metabolic Syndrome in humans are lacking. Therefore, the scientific justification is present but still preliminary, and further large-scale clinical trials are needed to confirm benefits for this specific condition.

More about Urolithin A
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Urolithin A

Products containing Urolithin A

Pure Encapsulations Renual